Virios Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Dogwood Therapeutics

10/05/2023 02:02

* Virios Therapeutics Inc  VIRI.OQ   VIRI.O  is expected
to show
no change in quarterly revenue when it reports  results on May
11. 
    * 
    * ​Refinitiv's mean analyst estimate for Virios Therapeutics
Inc
is for a loss of 20 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $2​, above​ its last closing price of $0.99.
​​​

This summary was machine generated May 10 at 01:02 GMT.  All
figures in US dollars  unless otherwise stated